Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.
Publication/Presentation Date
12-1-2019
Volume
29
Issue
12
First Page
1820
Last Page
1827
ISSN
1557-9077
Published In/Presented At
Huillard, O., Jouinot, A., Tlemsani, C., Brose, M. S., Arrondeau, J., Meinhardt, G., Fellous, M., De Sanctis, Y., Schlumberger, M., & Goldwasser, F. (2019). Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial. Thyroid : official journal of the American Thyroid Association, 29(12), 1820–1827. https://doi.org/10.1089/thy.2018.0784
Disciplines
Medicine and Health Sciences
PubMedID
31860408
Department(s)
Hematology-Medical Oncology Division
Document Type
Article
COinS